Shareholder plans sale of 2,634 shares under Rule 144

A holder of common shares of CW has filed a Rule 144 notice to sell 2,634 shares through UBS Financial Services on the NYSE, with an aggregate market value of 1,649,611.39.

Accepted by SEC EDGAR 02/04/2026 - 04:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of common shares of CW has filed a Rule 144 notice to sell 2,634 shares through UBS Financial Services on the NYSE, with an aggregate market value of 1,649,611.39. The filing notes total shares outstanding of 36,874,638 and an approximate sale date of 02/04/2026. The shares were acquired on 02/03/2026 via a performance stock vest from the issuer for the same 2,634-share amount.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CW disclose?

The Form 144 for CW discloses a planned sale of 2,634 common shares on the NYSE. The shares have an aggregate market value of 1,649,611.39 and are being sold under Rule 144 by an existing holder.

How many CW shares are planned for sale under Rule 144?

The filing shows a planned sale of 2,634 CW common shares. These shares are to be sold through UBS Financial Services on the NYSE, with an aggregate market value reported as 1,649,611.39 at the time of the notice.

When were the CW shares acquired and how?

The 2,634 CW common shares were acquired on 02/03/2026 through a performance stock vest from the issuer. The same date is listed for payment, described as “n/a” for the nature of payment, consistent with a vesting transaction.

What is the total number of CW shares outstanding in this filing?

The notice states that 36,874,638 CW common shares are outstanding. This figure provides context for the planned sale of 2,634 shares, indicating that the transaction represents a very small portion of the total share base.

On which exchange will the CW shares be sold and through which broker?

The planned sale of 2,634 CW common shares is to occur on the NYSE. The filing lists UBS Financial Services Inc., located in Weehawken, New Jersey, as the broker handling the transaction under Rule 144.

What does the Form 144 representation about material information mean for CW?

The person for whose account the CW shares are to be sold represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations, which is a standard Rule 144 representation for such planned sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001836011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Curtiss-Wright Corporation
SEC File Number	001-00134
Address of Issuer	130 Harbour Place Drive, Suite 300 Davidson NORTH CAROLINA 28036
Phone	973-541-3753
Name of Person for Whose Account the Securities are To Be Sold	Kevin Rayment
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2634	1649611.39	36874638	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/03/2026	performance stock vest	issuer			2634	02/03/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Kevin Rayment
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)